ATRX and neoplasm: GSEA of RCAS/Ntv-a tumors demonstrated differential engagement of cell cycle pathways in ATRX-deficient models relative to ATRX-intact counterparts, implicating tumor cell autonomous molecular mechanisms (Fig. 2c; Supplementary Data 3).